Brett Favre wants us to feel sorry for him. He says he’s being unfairly raked over the coals, his reputation tarnished, over ...
Brett Favre was diagnosed with Parkinson's disease in January after he began having trouble using his right arm and was ...
Leerink Partners analyst David Risinger has maintained their neutral stance on ABBV stock, giving a Hold rating on September 13. David ...
On Tuesday, former NFL quarterback Brett Favre revealed he has Parkinson's disease. Favre said five specialists told him they ...
SIOUX FALLS S.D. (KELO) –Former Green Bay Packers quarterback Brett Favre recently announced that he has been diagnosed with ...
The phase 3 Tempo-1 trial for tavapadon, a dopamine receptor partial agonist, demonstrated significant efficacy as a monotherapy in early Parkinson's disease. Patients receiving the drug at doses of 5 ...
The Phase III TEMPO-1 trial enrolled 529 adults aged between 40 and 80 years, diagnosed with Parkinson’s for less than three ...
A new study shows that automatic speech recognition (ASR) systems trained on speech from people with Parkinson’s disease are ...
As Mark Hasegawa-Johnson combed through data from his latest project, he was pleasantly surprised to uncover a recipe for ...
Zacks.com on MSN7h
ABBV's Newly Added Parkinson's Disease Drug Meets Second Study GoalAbbVie ABBV announced positive top-line results from the pivotal phase III TEMPO-1 study which evaluated its recently ...
"There's definitely a connection between the gut and brain in Parkinson's Disease," said Dr. Prarthana Prakash.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback